Summit Therapeutics Inc. (SMMT)

10h ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum

8d ago, source:

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held ...

Commit To Buy Summit Therapeutics At $3, Earn 24.6% Annualized Using Options

15d ago, source: Nasdaq

Investors eyeing a purchase of Summit Therapeutics Inc (Symbol: SMMT) stock, but cautious about paying the going market price of $3.87/share, might benefit from considering selling puts among the ...

Analysts Eye Summit Therapeutics' Ivonescimab As Potential Challenger To Merck's Keytruda in Lung Cancer Treatment

on MSN ago, source:

Stifel initiated coverage on Summit Therapeutics Inc (NASDAQ:SMMT), noting its main product ivonescimab, shows promising ...

Summit Therapeutics appoints genomics expert to board

6d ago, source: Investing

MIAMI - Summit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced the immediate appointment of Mostafa Ronaghi, PhD, to its Board of Directors, expanding the company's leadership with a veteran in ...

Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors

6d ago, source: Stockhouse

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Mostafa Ronaghi, PhD, has been ...

Myeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

2d ago, source:

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage biotechnology company advancing RNA immunotherapies to conquer ...

Protagenic Therapeutics, Inc.: Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

1d ago, source:

Chief Operating Officer to Present Key Advances at Peptide Therapeutics Summit NEW YORK, NY / ACCESSWIRE / April 17, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a pioneer in biopharmaceutical ...

Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum

8d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Summit Therapeutics Inc.

21d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...